Understanding Control and Mechanisms of Shoulder Instability in FSHD
3 other identifiers
observational
14
1 country
1
Brief Summary
The aim of this study is to identify factors for shoulder instability in people with Facioscapulohumeral dystrophy (FSHD). FSHD is a non-life limiting condition with symptoms presenting in the second decade of life (Evangelista et al., 2016). Between 2500 to 3000 people are diagnosed with FSHD in the UK and it is the third most common dystrophy. The overall prevalence is 1: 20,000 and on average 52 people are newly diagnosed with FSHD each year (Emery, 1991; Padberg et al., 1995; UK, 2020) As the disease progresses, patients lose the ability to adequately control muscles around the shoulder girdle, possibly contributing to the development of shoulder instability i.e. partial or complete dislocation of the shoulder joint (Bergsma, Cup, Geurts, \& De Groot, 2015; Bergsma, Cup, Janssen, Geurts, \& de Groot, 2017; Mul et al., 2016). Loss of control around the shoulder is also thought to contribute to pain and a reduced capacity to perform tasks above shoulder height. Additionally, the development of fatigue and chronic pain further limit patient's abilities and engagement with rehabilitation. If we better understand the mechanisms associated with instability, we can better target physiotherapy interventions to improve rehabilitation. If we identify specific patterns of activity associated with instability, these could be addressed through personalised and improved exercise prescription and rehabilitation. Additionally, we may identify causes of instability for which physiotherapy or exercise programmes may not be appropriate, therefore ensuring patients are referred to the correct service in a timely manner, improving patient outcomes and allocating resources more appropriately.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedStudy Start
First participant enrolled
March 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2022
CompletedFebruary 1, 2023
January 1, 2023
7 months
January 27, 2022
January 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Kinematic features of movement: joint angles (degrees)
Range of movement values and associated derivatives will be reported for the associated movement tasks.
Day 1
Kinematic features of movement: displacement (mm)
Displacement values and associated derivatives will be reported for associated movement tasks.
Day 1
Kinetic variables related to the movement tasks: Force (Nm)
Force values for the strength testing, joint contact and muscle force values will be reported for associated movement tasks.
Day 1
Muscle activity patterns related to the movement tasks: Surface electromyography (mv)
Muscle activity patterns related to the movement tasks will be reported for associated movement tasks.
Day 1
Ultrasound imaging: Muscle architecture parameters (mm)
Muscle architecture parameters where possible (Muscle thickness)
Day 1
Study Arms (2)
People affected by FSHD
Participants with a diagnosis of FSHD. 3D movement analysis session including surface electromyography and Ultrasound.
Age matched control group
Participants without a diagnosis of FSHD. 3D movement analysis session including surface electromyography and Ultrasound
Interventions
Single measurement session of 3D movement analysis with surface electromyography for upper limb movements and ultrasound measurements of upper muscles
Eligibility Criteria
This study will consist of people aged 18 years of age and older. The two groups will include people with (people affected by FSHD) and without FSHD (age matched controls).
You may qualify if:
- Stratified groups
- Able to lift arms above shoulder height (n=3)
- Unable to lift arms above shoulder height (n=2)
- Post Scapulothoracic shoulder arthrodesis (n=2)
- Diagnosed with FSHD
- Aged 18 years and older
You may not qualify if:
- Recent trauma to the shoulder within the last 3 months on the arm being assessed that has not resolved
- Recent surgery to the thorax or upper limb in the last 6 months
- Previous history of fracture to the shoulder joint being assessed
- Co-existing neurological pathologies or additional musculoskeletal injuries to the upper limb being assessed
- Age Matched Controls
- \- People aged 18 years and older
- Any previous presentation to a health care professional with a diagnosis of shoulder instability
- Previous shoulder injury within the last 3 months on the arm being assessed that has not resolved
- Any co-existing neurological pathologies or deficits
- Any previous surgical intervention on the arm being assessed
- Currently undergoing or awaiting medical management, diagnostic investigations or rehabilitation on the arm being assessed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Liverpoollead
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trustcollaborator
- Bournemouth Universitycollaborator
- Keele Universitycollaborator
Study Sites (1)
Robert Jones & Agnes Hunt Orthopaedic Hospital
Oswestry, Gobowen, SY10 7AG, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2022
First Posted
February 15, 2022
Study Start
March 25, 2022
Primary Completion
October 21, 2022
Study Completion
October 21, 2022
Last Updated
February 1, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
The anonymised final trial dataset and anonymised 3D movement data files will be stored on the University of Liverpool data repository. The anonymised dataset associated with the University of Liverpool data repository will be assigned a Digital object identifier and will be openly available.